Evidence map›Paper›PMID 31632511›Full record

ReviewAmerican journal of translational research2019

An emerging tumor invasion mechanism about the collective cell migration.

Yang Yang, Hongmei Zheng, Yuting Zhan, Songqing Fan

Abstract readReview
In one paragraph

Review in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Watercress (Life (Basel, Switzerland) · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. COMethods and protocols · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yang YangDepartment of Pathology, The Second Xiangya Hospital of Central South University Changsha, Hunan, China.
Hongmei ZhengDepartment of Pathology, The Second Xiangya Hospital of Central South University Changsha, Hunan, China.
Yuting ZhanDepartment of Pathology, The Second Xiangya Hospital of Central South University Changsha, Hunan, China.
Songqing FanDepartment of Pathology, The Second Xiangya Hospital of Central South University Changsha, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditionally, the metastasis has been detected in the late stage of the cancer, which mostly leads to death. The classical opinion about tumor metastasis is that tumor cell migration begins with the single tumor cell and goes through a series of complicated procedures, and lastly arrives and survives at distant tissues and organs. However, emerging studies have found a new migration mechanism called collective cell migration in many cancers. The collective cell migration could move as clusters with the tight cell-cell junction in the tumor microenvironments, toward the traction established by the leader cells. In addition, the collective cell migration has been shown to have higher invasive capacity and higher resistance to the clinical treatments than the single tumor cell migration. Interestingly, the collective clusters of tumor cells have been detected in the early stage of the cancer patient, which has led to the understanding of the significance of early cancer screenings. Here, we reviewed the major principles and guidance of the collective cell migration mechanisms, and the specific manifestations in the different tumors such as breast cancer and lung cancer.

Indexed as

collective cell migrationInvasionmetastasismigration

Identifiers

PMID31632511
PMCPMC6789225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.